Title
|
|
|
|
1,4-diarylpiperazines and analogs as anti-tubercular agents : synthesis and biological evaluation
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
Despite progress in modern chemotherapy to combat tuberculosis, the causative pathogen Mycobacterium tuberculosis (M.tb.) is far from eradicated. Bacillary resistance to anti-mycobacterial agents, bacillary persistence and human immunodeficiency virus (HIV) co-infection hamper current drug treatment to completely cure the infection, generating a constant demand for novel drug candidates to tackle these problems. A small library of novel heterocyclic compounds was screened in a rapid luminometric in vitro assay against the laboratory M.tb. strain H37Rv. A group of amidines was found to have the highest potency and was further evaluated for acute toxicity against C3A hepatocytes. Next, the most promising compounds were evaluated for activity against a multi-drug resistant clinical isolate. The group of amidines was also tested for their ability to kill intracellular M.tb. residing in mouse J774A.1 macrophages. Finally, we report on a correlation between the structural differences of the compounds and their anti-mycobacterial activity. |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
European journal of medicinal chemistry. - Paris, 1974, currens
| |
Publication
|
|
|
|
Paris
:
2012
| |
ISSN
|
|
|
|
0223-5234
| |
DOI
|
|
|
|
10.1016/J.EJMECH.2011.12.035
| |
Volume/pages
|
|
|
|
49
(2012)
, p. 95-101
| |
ISI
|
|
|
|
000302033300009
| |
Full text (Publisher's DOI)
|
|
|
|
| |
Full text (publisher's version - intranet only)
|
|
|
|
| |
|